Tech Firms Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
Tech firms were leading European equities traded in the US as American depositary receipts moderately higher late Thursday morning, rising 0.50% to 1,448.39 on the S&P Europe Select ADR Index. From co
Jefferies Maintains Bicycle Therapeutics(BCYC.US) With Buy Rating, Cuts Target Price to $56
Jefferies analyst Kelly Shi maintains $Bicycle Therapeutics(BCYC.US)$ with a buy rating, and adjusts the target price from $59 to $56.According to TipRanks data, the analyst has a success rate of 30.4
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading
European equities traded in the US as American depositary receipts fell in Monday trading, declining 0.53% to 1,420.98 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyc
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading
European equities traded in the US as American depositary receipts were moving sharply lower Wednesday morning, falling 1.39% to 1,402.95 on the S&P Europe Select ADR Index. Gainers in continental Eur
Bicycle Therapeutics (NASDAQ:BCYC) Delivers Shareholders Solid 16% CAGR Over 5 Years, Surging 6.1% in the Last Week Alone
It hasn't been the best quarter for Bicycle Therapeutics plc (NASDAQ:BCYC) shareholders, since the share price has fallen 12% in that time. But that scarcely detracts from the really solid long ter
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M
European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower
European equities traded in the US as American depositary receipts were moving higher Friday morning, rising 0.63% to 1,424.72 on the S&P Europe Select ADR Index. However, the gain likely won't be eno
Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
Emerging clinical pharmacokinetic and safety profiles of Bicycle Toxin Conjugates demonstrate differentiation compared to antibody drug conjugates Trial-in-progress poster outlines registrational Phase 2/3
Cantor Fitzgerald Maintains Bicycle Therapeutics(BCYC.US) With Buy Rating
Cantor Fitzgerald analyst Li Watsek maintains $Bicycle Therapeutics(BCYC.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 31.7% and a total average return of -11.6%
Gold Falls Sharply; US Composite PMI Surges In May
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 250 points on Thursday.The Dow traded down 0.65% to 39,414.01 while the NASDAQ rose 0.84% to 16,942.51. The
Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
Tech stocks led European equities traded in the US as American depositary receipts modestly higher Thursday morning, rising 0.4% to 1,428.1 on the S&P Europe Select ADR Index. From continental Europe,
E.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones index falling around 250 points on Thursday.Shares of e.l.f. Beauty, Inc. (NYSE:ELF) rose sharply during Thursday's session after the company reported better
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersOneMedNet (NASDAQ:ONMD) shares moved upwards by 103.2% to $1.0 during Thursday's pre-market session. The company's market cap stands at $23.7 million. iSpecimen (NASDAQ:ISPC) stock moved upward
Bicycle Therapeutics: Enhanced balance sheet predicts a cash position of around $1 billion to extend the expected financial position through the second half of 2027
Bicycle Therapeutics: Enhanced balance sheet predicts a cash position of around $1 billion to extend the expected financial position through the second half of 2027
Bicycle Therapeutics Announces $555 Million Private Equity Funding
Bicycle Therapeutics Announces $555 Million Private Equity Funding
Express News | Bicycle Therapeutics : Strengthens Balance Sheet, With Pro Forma Cash Position of About $1.0 Bln, Extending Expected Financial Runway Into 2H of 2027
Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
Financing includes participation from new and existing investors Strengthens balance sheet, with pro forma cash position of approximately $1.0 billion, extending expected financial runway into the second half of
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
European equities traded in the US as American depositary receipts fell Wednesday morning, declining 0.48% to 1,423.09 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led
No Data